Skip to content

The Effect of Nutrition Education in Women with type 2 Diabetes.

The Effect of Nutrition Education on Control Blood Sugar, Lipid Profile, liver Enzymes and Quality of life in Middle-aged Women with type 2 Diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181118041687N1
Enrollment
100
Registered
2020-09-30
Start date
2018-06-15
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes type 2. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group: Educational intervention with 4 sessions of nutrition training class in groups of 5-10 people with educational content of sessions including: stages of diabetes pro
The second session was held two weeks after the start of the study by small group techniques, the third session was held four weeks after the start of the study as an interactive lecture and the fourt

Sponsors

Larestan University of Medical Sciences
Lead Sponsor
Shiraz University of Medical Sciences
Collaborator

Eligibility

Sex/Gender
Female
Age
30 Years to 59 Years

Inclusion criteria

Inclusion criteria: Middle Aged WWomen are 30 to 59 Years Old. Have a one Year or more History of type 2 Diabetes. Willing to Participate in the Study. Use Oral Medications to Control your Blood Sugar. Do not take Insulin. Pregnant and lactating. Do not have any Special iIlnesses. Have no Thyroid Problems. There is no Definite Diet. Do not have Uncontrolled Diabetes. Have Mental Disabilities. Sleep, Tranquilizer, Antihistamines and Immune System Inhibitors.

Exclusion criteria

Exclusion criteria: One does not want to Continue to Study. The Person will Absent more than one Meeting. The Person leaves the Pre-test or Post-test. Tests are Misleading.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose above 126mg / dl and high blood glucose levels of 180mg / dl. Timepoint: The beginning of the study (before intervention) and three months after the intervention began. Method of measurement: blood test.;Hemogolobin A1C above 6.5%. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Koromatografi.;Fasting Ansulin. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Fasting serum insulin concentration using a commercial kit.

Secondary

MeasureTime frame
Weight. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Weight using seca scales with an accuracy of one hundred grams.;Waist. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Scales.;Body mass index. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Ratio of weight(in terms of kilogram) to the power of height(in terms of meters).;Blood pressure. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Using a standard mercury barometer.;High density of lipoprotein cholestrol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Low density of lipoprotein cholestrol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Triglyceride. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Cholesterol. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Alanine trans aminase. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Aspartate transaminase. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Blood test.;Homeostasis model assessment beta cell. Timepoint: The bigining of the study (befor intervention) and teree monthe after the intervention began. Method of measurement: Based on fasting glucose and insulin concentrations.;Homeostasis model assessment insulin

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Dezhaloon

Shiraz University of Medical Sciences

dezhalooneli@yahoo.com+98 71 5888 8105

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026